CAR T-cell therapy is an FDA-approved treatment for patients who are up to 25 years old with second or later relapsed or refractory B-cell acute lymphoblastic leukemia (ALL). Dana-Farber/Boston Children’s Cancer and Blood Disorders Center is a certified treatment center offering this new therapy.

Learn more about CAR T-cell therapy:

Leave a Reply

Let us help fight cancer. Share your knowledge.


Latest news, views, insights and trends on cancer treatment, discovery and support